• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Belarus Pharmaceuticals and Healthcare Report Q2 2009 - Product Image

Belarus Pharmaceuticals and Healthcare Report Q2 2009

  • Published: March 2009
  • Region: Belarus
  • 56 Pages
  • Business Monitor International

BMI's Belarus Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Belarus' pharmaceuticals and healthcare industry.

Q209 sees Belarus added to BMI’s Pharmaceuticals & Healthcare quarterly reports for the first time, bringing the total coverage universe up to 71 markets. Of these countries, Belarus occupies 59th position in our Business Environment Rankings, highlighting its status as a true emerging pharmaceutical market. On a regional scale, Belarus places 18th in Central and Eastern Europe (CEE), ahead only of Commonwealth of Independent States (CIS) counterparts Moldova and Uzbekistan.

Belarus’ pharmaceutical market has undergone a period of robust growth in recent years, a trend we believe will prevail. Over the next five years, sales of pharmaceuticals, which include prescription drugs and over-the-counter medicines, will increase from US$0.62bn to US$1.28bn, representing a compound annual growth rate (CAGR) of 15.5%, among the highest in CEE. Nevertheless, growth from a low per capita spending base means that access to innovative therapies will remain limited. This trend is reinforced by nationalistic READ MORE >

Executive Summary
Belarus Pharmaceuticals And Healthcare Industry SWOT
Belarus Political SWOT
Belarus Economic SWOT
Belarus Business Environment SWOT
Pharmaceutical Business Environment Ratings
Table: Central And Eastern Europe Pharmaceuticals Business Environment Ratings
Limits To Potential Returns
Risks To Realisation Of Returns
Belarus Market Summary
Regulatory Regime
Counterfeit Drugs
Intellectual Property Rights
Pricing And Reimbursement
Industry Developments
Epidemiology
Table: Disease Burden In Central And Eastern Europe, DALY’s Lost Per 100,000 Population
Healthcare Sector
Industry Forecast Scenario
Overall Market Forecast
Table: Belarus’ Drug Market Expenditure, 2004-2013
Key Growth Factors – Industry
Table: Belarus’ Health Expenditure, 2004-2013
Key Growth Factors – Macroeconomic
Table: Belarus – Economic Activity
Prescription Drug Market Forecast
Table: Belarus’ Prescription Drug Market, 2004-2013 (BYR mn unless otherwise stated)
Table: Top 10 ATC Level 2 Codes In Belarus By Pharmacy Sales, 2006-2007
Table: Top 10 ATC Level 2 Codes In Belarus By Hospital Sales, 2006-2007
Patented Drug Market Forecast
Table: Belarus’ Patented Drug Market, 2004-2013
Generic Drug Market Forecast
Table: Belarus’ Generic Drug Market, 2004-2013
OTC Drug Market Forecast
Table: Belarus’ OTC Market, 2004-2013 (BYR mn unless otherwise stated)
Pharmaceutical Export/Import Forecast
Table: Belarus’ Pharmaceutical Trade Balance, 2004-2013 (US$mn)
Other Healthcare Data Forecasts
Table: Belarus’ Other Health Indicators, 2004-2013
Key Risks To BMI’s Forecasts
Competitive Landscape
Table: The Top 10 Drugmakers In Belarus In H108 According To Pharmacy Sales
Table: The Top 10 Drugmakers In Belarus In H108 According To Hospital Sales
Table: The Top 10 Trade Names In Belarus According To Pharmacy Sales, 2007
Domestic Drugmakers
Foreign Drugmakers
Pharmaceutical Wholesale And Retail
Research And Development
Company Profiles.
Belbiopharm
Lekpharm
Country Snapshot: Belarus Demographic Data
Section 1: Population
Table: Demographic Indicators, 2005-2030
Table: Rural/Urban Breakdown, 2005-2030
Section 2: Education And Healthcare
Table: Education, 2000-2005
Table: Vital Statistics, 2005-2030
Section 3: Labour Market And Spending Power
Table: Employment Indicators, 2001-2006
Table: Consumer Expenditure, 2000-2012 (US$)
Table: Average Annual Wages, 2005-2009
BMI Forecast Modelling
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources

- Belbiopharm
- Lekpharm

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos